Tygh Capital Management Inc. decreased its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 62.6% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 54,335 shares of the company’s stock after selling 91,114 shares during the period. Tygh Capital Management Inc. owned 0.06% of Acadia Healthcare worth $2,683,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. American Century Companies Inc. raised its position in Acadia Healthcare by 5.3% in the second quarter. American Century Companies Inc. now owns 130,941 shares of the company’s stock valued at $6,466,000 after buying an additional 6,553 shares in the last quarter. Geneva Advisors LLC raised its position in Acadia Healthcare by 11.3% in the second quarter. Geneva Advisors LLC now owns 67,810 shares of the company’s stock valued at $3,348,000 after buying an additional 6,890 shares in the last quarter. Federated Investors Inc. PA purchased a new position in Acadia Healthcare during the second quarter valued at approximately $1,406,000. William Blair Investment Management LLC raised its position in Acadia Healthcare by 1,247.4% in the second quarter. William Blair Investment Management LLC now owns 2,128,972 shares of the company’s stock valued at $105,129,000 after buying an additional 1,970,965 shares in the last quarter. Finally, Blair William & Co. IL raised its position in Acadia Healthcare by 54.2% in the second quarter. Blair William & Co. IL now owns 12,869 shares of the company’s stock valued at $635,000 after buying an additional 4,524 shares in the last quarter.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) opened at 45.55 on Friday. Acadia Healthcare Company, Inc. has a one year low of $32.54 and a one year high of $54.34. The firm has a market capitalization of $4.00 billion, a P/E ratio of 500.55 and a beta of 1.15. The firm has a 50-day moving average price of $50.20 and a 200 day moving average price of $45.31.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The company had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.73 earnings per share. Equities research analysts anticipate that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Acadia Healthcare Company, Inc. (ACHC) Shares Sold by Tygh Capital Management Inc.” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/08/25/acadia-healthcare-company-inc-achc-shares-sold-by-tygh-capital-management-inc.html.

Several analysts have recently issued reports on ACHC shares. BidaskClub cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Friday, August 18th. Zacks Investment Research cut Acadia Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday, August 1st. Deutsche Bank AG raised their price target on Acadia Healthcare from $58.00 to $60.00 and gave the company a “buy” rating in a research note on Monday, July 31st. Craig Hallum restated a “buy” rating and issued a $65.00 price target (up from $52.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. Finally, UBS AG restated a “positive” rating and issued a $60.00 price target (up from $54.00) on shares of Acadia Healthcare in a research note on Monday, July 31st. One research analyst has rated the stock with a sell rating, four have issued a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $59.21.

In other news, President Brent Turner sold 206,252 shares of the business’s stock in a transaction on Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $10,454,913.88. Following the sale, the president now owns 81,106 shares of the company’s stock, valued at $4,111,263.14. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William Grieco sold 2,000 shares of the business’s stock in a transaction on Friday, June 16th. The stock was sold at an average price of $45.42, for a total transaction of $90,840.00. Following the completion of the sale, the director now directly owns 47,013 shares in the company, valued at approximately $2,135,330.46. The disclosure for this sale can be found here. In the last three months, insiders sold 3,962,387 shares of company stock worth $197,947,257. 11.10% of the stock is currently owned by insiders.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Stock Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related stocks with our FREE daily email newsletter.